Yi-Kai Zhang
Overview
Explore the profile of Yi-Kai Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ye S, Hu Y, Zhou Q, Zhang H, Xia Z, Zhao S, et al.
ACS Omega
. 2023 Oct;
8(39):36543-36552.
PMID: 37810655
Early screening and administration of DKD are beneficial for renal outcomes of type 2 diabetic patients. However, the current early diagnosis using the albuminuria/creatine ratio (ACR) contains limitations. This study...
2.
Liu S, Chen C, Zhang Y, Zhong W, Wu Y, Liu S, et al.
Biomark Res
. 2023 Mar;
11(1):26.
PMID: 36879350
Background: ADJUVANT-CTONG1104 reported a favorable survival outcome from adjuvant gefitinib treatment over chemotherapy in EGFR-mutant non-small cell lung cancer (NSCLC) patients. However, heterogeneous benefit from EGFR-TKIs and chemotherapy demands further...
3.
Jiang J, Xie Y, Zhang Y, Li M, Zhao Y, Wen Z, et al.
Zhongguo Zhong Yao Za Zhi
. 2017 Nov;
42(15):2883-2888.
PMID: 29139252
In order to obtain the characteristics and incidence of adverse reactions of Shuxuening injection (Xingxue), the design method of a multi-center, large sample intensive monitoring in the hospitals was adopted....
4.
Jiang J, Xie Y, Zhang Y, Zhang Y, Wang Z, Han B
Zhongguo Zhong Yao Za Zhi
. 2017 Sep;
41(24):4516-4520.
PMID: 28936832
To understand the medication characteristics of Xingxue@Shuxuening solutions in the real world, multi-center, large-sample-size registration design method is adopted in this study. Between October 2012 and October 2015, hospitalized patients...
5.
Jin D, Xie Y, Zhang Y, Jiang J, Zhang Y, Zhuang Y
Zhongguo Zhong Yao Za Zhi
. 2017 Sep;
41(11):2007-2014.
PMID: 28901093
To understand the clinical characteristics and distribution of combined treatment of Chinese and western medicine in diabetes deaths, the hospitalization information of diabetes deaths from HIS system of 20 national...
6.
Zhou Y, Gu Y, Qi B, Zhang Y, Li X, Fang W
J Zhejiang Univ Sci B
. 2017 Apr;
18(4):316-323.
PMID: 28378569
Porcine circovirus type 2 (PCV2) has recently been reported to elicit the unfolded protein response (UPR) via activation of the PERK/eIF2α (RNA-activated protein kinase-like endoplasmic reticulum (ER) kinase/eukaryotic initiation factor...
7.
Ma J, Zhang Y, Li R, Ye J, Li H, Zhang Y, et al.
Eur J Pharmacol
. 2015 Jun;
764:228-239.
PMID: 26086859
Tetrandrine (Tet), a bisbenzylisoquinoline alkaloid, has been reported to possess anti-tumour activity. However, its effects on human glioma remain unknown. In this study, we demonstrated that Tet inhibited human glioma...
8.
Zhang Y, Zhu D, Zhang Y, Chen H, Xiang J, Lin X
PLoS One
. 2015 Feb;
10(2):e0116971.
PMID: 25719552
Soil acidification is the main problem in the current rice production. Here, the effects of low pH on the root growth, reactive oxygen species metabolism, plasma membrane functions, and the...
9.
Zhao S, Jiang D, Xu P, Zhang Y, Shi H, Cao H, et al.
Ann Clin Microbiol Antimicrob
. 2015 Feb;
14:7.
PMID: 25643932
Background: To investigate the drug resistant gene profiles and molecular typing of Acinetobacter baumannii isolates collected from clinical specimens in a comprehensive hospital, Jiangsu province. Methods: This study included 120...
10.
Cao W, Liu D, Zhang Y, Wang X, Chang Y, Yang Q, et al.
Zhong Yao Cai
. 2011 Mar;
33(10):1538-41.
PMID: 21355187
Objective: To analyze the content of proteins,amino acids and inorganic elements of Holotrichia diomphalia in different growing areas as the references for quality evaluation and reasonable application of them. Methods:...